临床眼科杂志
臨床眼科雜誌
림상안과잡지
JOURNAL OF CLINICAL OPHTHALMOLOGY
2015年
4期
365-370
,共6页
张惟%陈松%王继明%段红涛%孔佳慧%王月欣%董蒙%毕雪%宋建
張惟%陳鬆%王繼明%段紅濤%孔佳慧%王月訢%董矇%畢雪%宋建
장유%진송%왕계명%단홍도%공가혜%왕월흔%동몽%필설%송건
脐带间充质干细胞%神经干细胞%神经元%糖尿病视网膜病变
臍帶間充質榦細胞%神經榦細胞%神經元%糖尿病視網膜病變
제대간충질간세포%신경간세포%신경원%당뇨병시망막병변
Umbilical cord mesenchymal stem cells%Neural stem cells%Neuron%Biabetic retinopathy
目的:研究人脐带分离的间充质干细胞( UC-MSC)在体外分离、培养、扩增和鉴定以及向神经干细胞和神经元细胞分化的可能性,为临床治疗糖尿病视网膜病变( DR )神经损伤提供理论基础。方法选用足月妊娠剖宫产健康胎儿的脐带,剔除动静脉后采用贴壁法分离得到UC-MSC,选用20%FBS血清培养液进行原代培养,经传代培养、流式细胞检测后,用神经分化培养基诱导UC-MSC分别向神经干细胞和神经元细胞分化,在荧光显微镜下观察细胞形态,并以免疫荧光和RT-PCR方法进行鉴定。结果 UC-MSC呈贴壁生长,倒置显微镜可见细胞呈形态相对均一的梭形细胞,呈放射状排列生长或旋涡状生长。流式细胞检测表明这些细胞表达CD105( SH2)、CD73(SH3)及CD90等MSC标志物;不表达CD34、CD45、CD11b和CD19。经神经干细胞分化诱导后,细胞开始聚集形成大小不等的细胞簇形成悬浮的细胞团;RT-PCR及免疫荧光检测表明,其NSE和NeuroD1阳性细胞分别达(87.3±14.7)%、(72.6±11.8)%。经神经元细胞分化诱导后,细胞呈神经元样的突起,细胞胞体饱满、折光性明显变强;RT-PCR及免疫荧光检测表明,其MAP2和NF-M阳性细胞分别达(43.1±10.3)%、(69.4±19.5)%。结论在一定的诱导条件下,UC-MSC能向神经细胞分化,可能作为DR神经损伤的细胞移植治疗来源。
目的:研究人臍帶分離的間充質榦細胞( UC-MSC)在體外分離、培養、擴增和鑒定以及嚮神經榦細胞和神經元細胞分化的可能性,為臨床治療糖尿病視網膜病變( DR )神經損傷提供理論基礎。方法選用足月妊娠剖宮產健康胎兒的臍帶,剔除動靜脈後採用貼壁法分離得到UC-MSC,選用20%FBS血清培養液進行原代培養,經傳代培養、流式細胞檢測後,用神經分化培養基誘導UC-MSC分彆嚮神經榦細胞和神經元細胞分化,在熒光顯微鏡下觀察細胞形態,併以免疫熒光和RT-PCR方法進行鑒定。結果 UC-MSC呈貼壁生長,倒置顯微鏡可見細胞呈形態相對均一的梭形細胞,呈放射狀排列生長或鏇渦狀生長。流式細胞檢測錶明這些細胞錶達CD105( SH2)、CD73(SH3)及CD90等MSC標誌物;不錶達CD34、CD45、CD11b和CD19。經神經榦細胞分化誘導後,細胞開始聚集形成大小不等的細胞簇形成懸浮的細胞糰;RT-PCR及免疫熒光檢測錶明,其NSE和NeuroD1暘性細胞分彆達(87.3±14.7)%、(72.6±11.8)%。經神經元細胞分化誘導後,細胞呈神經元樣的突起,細胞胞體飽滿、摺光性明顯變彊;RT-PCR及免疫熒光檢測錶明,其MAP2和NF-M暘性細胞分彆達(43.1±10.3)%、(69.4±19.5)%。結論在一定的誘導條件下,UC-MSC能嚮神經細胞分化,可能作為DR神經損傷的細胞移植治療來源。
목적:연구인제대분리적간충질간세포( UC-MSC)재체외분리、배양、확증화감정이급향신경간세포화신경원세포분화적가능성,위림상치료당뇨병시망막병변( DR )신경손상제공이론기출。방법선용족월임신부궁산건강태인적제대,척제동정맥후채용첩벽법분리득도UC-MSC,선용20%FBS혈청배양액진행원대배양,경전대배양、류식세포검측후,용신경분화배양기유도UC-MSC분별향신경간세포화신경원세포분화,재형광현미경하관찰세포형태,병이면역형광화RT-PCR방법진행감정。결과 UC-MSC정첩벽생장,도치현미경가견세포정형태상대균일적사형세포,정방사상배렬생장혹선와상생장。류식세포검측표명저사세포표체CD105( SH2)、CD73(SH3)급CD90등MSC표지물;불표체CD34、CD45、CD11b화CD19。경신경간세포분화유도후,세포개시취집형성대소불등적세포족형성현부적세포단;RT-PCR급면역형광검측표명,기NSE화NeuroD1양성세포분별체(87.3±14.7)%、(72.6±11.8)%。경신경원세포분화유도후,세포정신경원양적돌기,세포포체포만、절광성명현변강;RT-PCR급면역형광검측표명,기MAP2화NF-M양성세포분별체(43.1±10.3)%、(69.4±19.5)%。결론재일정적유도조건하,UC-MSC능향신경세포분화,가능작위DR신경손상적세포이식치료래원。
Objective To explore a method to isolate and culture umbilical cord mesenchymal stem cells ( UC-MSC) and to induce them into neural differentiation.To provide a basis for the clinical treatment of nerve damages in dia-betic retinopathy (DR).Methods The umbilical cords (UC) were collected from women who received C-section and gave birth to full-term healthy neonates.Written consents and approval of the Clinic Ethnics Committee were obtained prior to the study.UC-MSC were isolated by adherent culture in the medium contains 20%fetal bovine serum ( FBS) , and then maintained in the medium contains 10%FBS.The cellular morphology was studied using fluorescence microscope.Surface markers were examined with flow cytometry.MSC was then induced to differentiate towards neuron stem cells and neurons. Neural markers were detected by immunocytochemistry and RT-PCR.Results MSC grew adherently and cells were rela-tively uniform in spindle shape arranged in spiral or radial formation.FACS revealed that these cells expressed common markers of MSCs, such as CD105 (SH2), CD73 (SH3) and CD90.After induction, cells begin to aggregate to form clus-ters.Cells grew neuron-like protrusions, became plump, and refracted more strongly.RT-PCR and immunofluorescence showed that the NSE and NeuroD1-positive cells reached 87.3 ±14.7%and 72.6 ±11.8% respectively.MAP2 and NF-M-positive cells reached 43.1 ±10.3%and 69.4 ±19.5% respectively.Conclusion MSCs from human umbilical cord showed an important neural differentiation potential and may represent a novel candidate for the therapy for DR nerve dam-age.